Purple Biotech Ltd.

06/03/2024 | Press release | Distributed by Public on 06/03/2024 04:37

Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in[...]